These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

940 related articles for article (PubMed ID: 16859511)

  • 1. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells.
    Galliher AJ; Schiemann WP
    Breast Cancer Res; 2006; 8(4):R42. PubMed ID: 16859511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.
    Galliher AJ; Schiemann WP
    Cancer Res; 2007 Apr; 67(8):3752-8. PubMed ID: 17440088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
    Wendt MK; Schiemann WP
    Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta.
    Galliher-Beckley AJ; Schiemann WP
    Carcinogenesis; 2008 Feb; 29(2):244-51. PubMed ID: 18174260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.
    Sokol JP; Neil JR; Schiemann BJ; Schiemann WP
    Breast Cancer Res; 2005; 7(5):R844-53. PubMed ID: 16168131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells.
    Mori S; Kodaira M; Ito A; Okazaki M; Kawaguchi N; Hamada Y; Takada Y; Matsuura N
    PLoS One; 2015; 10(9):e0137486. PubMed ID: 26334633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II.
    Maeda M; Shintani Y; Wheelock MJ; Johnson KR
    J Biol Chem; 2006 Jan; 281(1):59-68. PubMed ID: 16267045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.
    Taylor MA; Amin JD; Kirschmann DA; Schiemann WP
    Neoplasia; 2011 May; 13(5):406-18. PubMed ID: 21532881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
    Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
    Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β.
    Parvani JG; Galliher-Beckley AJ; Schiemann BJ; Schiemann WP
    Mol Biol Cell; 2013 Nov; 24(21):3449-59. PubMed ID: 24006485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism.
    Lee YH; Albig AR; Regner M; Schiemann BJ; Schiemann WP
    Carcinogenesis; 2008 Dec; 29(12):2243-51. PubMed ID: 18713838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.
    Wendt MK; Smith JA; Schiemann WP
    J Biol Chem; 2009 Dec; 284(49):34145-56. PubMed ID: 19822523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
    Taylor MA; Parvani JG; Schiemann WP
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors.
    Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
    Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene.
    Lam S; Wiercinska E; Teunisse AF; Lodder K; ten Dijke P; Jochemsen AG
    Breast Cancer Res Treat; 2014 Nov; 148(1):7-18. PubMed ID: 25257729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity.
    Bhowmick NA; Zent R; Ghiassi M; McDonnell M; Moses HL
    J Biol Chem; 2001 Dec; 276(50):46707-13. PubMed ID: 11590169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.
    Wang SE; Wu FY; Shin I; Qu S; Arteaga CL
    Mol Cell Biol; 2005 Jun; 25(11):4703-15. PubMed ID: 15899872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta control of cell proliferation.
    Huang SS; Huang JS
    J Cell Biochem; 2005 Oct; 96(3):447-62. PubMed ID: 16088940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.
    Wendt MK; Smith JA; Schiemann WP
    Oncogene; 2010 Dec; 29(49):6485-98. PubMed ID: 20802523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.